Trial · NCT05693935
Participant flow63
How many started, completed or left each group, period by period.
21 to 40 of 63
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind Period (8 Weeks) | Safety Analysis Set for Period 1 | Placebo to TV-44749 531 mg | 0 | |
| Double-blind Period (8 Weeks) | COMPLETED | Placebo | 119 | |
| Double-blind Period (8 Weeks) | COMPLETED | TV-44749 318 mg | 115 | |
| Double-blind Period (8 Weeks) | COMPLETED | TV-44749 425 mg | 121 | |
| Double-blind Period (8 Weeks) | COMPLETED | TV-44749 531 mg | 121 | |
| Double-blind Period (8 Weeks) | COMPLETED | Placebo to TV-44749 318 mg | 0 | |
| Double-blind Period (8 Weeks) | COMPLETED | Placebo to TV-44749 425 mg | 0 | |
| Double-blind Period (8 Weeks) | COMPLETED | Placebo to TV-44749 531 mg | 0 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | Placebo | 49 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | TV-44749 318 mg | 54 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | TV-44749 425 mg | 48 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | TV-44749 531 mg | 48 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | Placebo to TV-44749 318 mg | 0 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | Placebo to TV-44749 425 mg | 0 | |
| Double-blind Period (8 Weeks) | NOT COMPLETED | Placebo to TV-44749 531 mg | 0 | |
| Open-label Period (48 Weeks) | STARTED | Placebo | 0 | |
| Open-label Period (48 Weeks) | STARTED | TV-44749 318 mg | 100 | |
| Open-label Period (48 Weeks) | STARTED | TV-44749 425 mg | 107 | |
| Open-label Period (48 Weeks) | STARTED | TV-44749 531 mg | 112 | |
| Open-label Period (48 Weeks) | STARTED | Placebo to TV-44749 318 mg | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05693935/flow?page=2